| Novartis International AG (VTX:NOVN) Glivec Receives US Approval ... - ABN Newswire (press release) |
|
|
... pancreatitis, hepatic failure, exfoliative dermatitis, angioedema, Stevens-Johnson syndrome, renal failure, fluid retention, edema (including brain, ... |